Histopathological changes in tendinopathy-potential roles of BMPs?

Rheumatology (United Kingdom)

Volumn 52, Issue 12, 2013, Pages 2116-2126

  Lui, Pauline Po Yee ^a  

^a Hospital Authority   (Hong Kong)

Author keywords

BMPs; Pathogenesis; Tendinopathy; Tendinosis; Tendon derived stem progenitor cells

Indexed keywords

BIOLOGICAL FACTOR; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; CALCITONIN GENE RELATED PEPTIDE; CHORDIN; COLLAGENASE 3; FOLLISTATIN; GAG PROTEIN; NOGGIN; OSTEOGENIC PROTEIN 1; PROSTAGLANDIN E2; PROTEOGLYCAN; SMAD6 PROTEIN; SUBSTANCE P; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANGIOGENESIS; CARTILAGE CELL; CELL DIFFERENTIATION; CELL THERAPY; CIRCULATION; EFFECTOR CELL; EXTRACELLULAR MATRIX; HEALING; HISTOPATHOLOGY; HUMAN; INTRACELLULAR SIGNALING; METAPLASIA; NONHUMAN; OSSIFICATION; OSTEOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STEM CELL; TENDINITIS; TENDON;

BMPS; PATHOGENESIS; TENDINOPATHY; TENDINOSIS; TENDON-DERIVED STEM/PROGENITOR CELLS;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; METAPLASIA; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; STEM CELLS; STRESS, PHYSIOLOGICAL; TENDINOPATHY; TENDONS; WNT PROTEINS; WOUND HEALING;

EID: 84887711204     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket165     Document Type: Review

References (143)

1. Kannus P. Tendons-a source of major concern in competitive and recreational athletes. Scand J Med Sci Sports 1997;7:53-4.
2. U.S. Bureau of Labor Statistics. Occupational injuries and illnesses-counts, rates and characteristics. Washington, DC:Bureau of Labor Statistics, 1995.
3. Khan K, Cook J. The painful nonruptured tendon:clinical aspects. Clin Sports Med 2003;22:711-25.
4. Hart DA, Archambault JM, Kydd A et al. Gender and neurogenic variables in tendon biology and repetitive motion disorders. Clin Orthop Relat Res 1998;351:44-56.
5. September AV, Cook J, Handley CJ et al. Variants within the COL5A1 gene are associated with Achilles tendinopathy in two populations. Br J Sports Med 2009;43:357-65.
6. September AV, Nell EM, O'Connell K et al. A pathwaybased approach investigating the genes encoding interleukin-1b, interleukin-6 and the interleukin-1 receptor antagonist provides new insight into the genetic susceptibility of Achilles tendinopathy. Br J Sports Med 2011;45:1040-7.
7. Fu SC, Wang W, Pau HM et al. Increased expression of transforming growth factor-beta 1 in patellar tendinosis. Clin Orthop Relat Res 2002;400:174-83.
8. Rees JD, Maffulli N, Cook J. Management of tendinopathy. Am J Sports Med 2009;37:1855-67.
9. Alfredson H, Lorentzon R. Chronic tendon pain:no signs of chemical inflammation but high concentrations of the neurotransmitter glutamate Implications for treatment? Curr Drug Targets 2002;3:43-54.
10. Andersson G, Danielson P, Alfredson H et al. Nerverelated characteristics of ventral paratendinous tissue in chronic Achilles tendinosis. Knee Surg Sports Traumatol Arthrosc 2007;15:1272-9.
11. Danielson P, Andersson G, Alfredson H et al. Extensive expression of markers for acetylcholine synthesis and of M2 receptors in tenocytes in therapy-resistant chronic painful patellar tendon tendinosis-a pilot study. Life Sci 2007;80:2235-8.
12. Lian Ø, Dahl J, Ackermann PW et al. Pronociceptive and antinociceptive neuromediators in patellar tendinopathy. Am J Sports Med 2006;34:1801-8.
13. Scott A, Bahr R. Neuropeptides in tendinopathy. Front Biosci 2009;14:2203-11.
14. Scott A, Lian Ø, Bahr R et al. Increased mast cell numbers in human patellar tendinosis:correlation with symptom duration and vascular hyperplasia. Br J Sports Med 2008;42:753-7.
15. Millar NL, Hueber AJ, Reilly JH et al. Inflammation is present in early human tendinopathy. Am J Sports Med 2010;38:2085-91.
16. Fu SC, Chan KM, Rolf CG. Increased deposition of sulfated glycosaminoglycans in human patellar tendinopathy. Clin J Sport Med 2007;17:129-34.
17. Fu SC, Chan BP, Wang W et al. Increase expression of matrix metalloproteinase 1 (MMP1) in 11 patients with patellar tendinosis. Acta Orthop Scand 2002;73:658-62.
18. Jones GC, Corps AN, Pennington CJ et al. Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human Achilles tendon. Arthritis Rheum 2006;54:832-42.
19. Del Buono A, Oliva F, Longo UG et al. Metalloproteases and rotator cuff disease. J Shoulder Elbow Surg 2012;21:200-8.
20. Riley G. Tendinopathy-from basic science to treatment. Nat Clin Pract Rheumatol 2008;4:82-9.
21. Garofalo R, Cesari E, Vinci E et al. Role of metalloproteinases in rotator cuff tear. Sports Med Arthrosc 2011;19:207-12.
22. Xu Y, Murrell GA. The basic science of tendinopathy. Clin Orthop Relat Res 2008;466:1528-38.
23. Kannus P, Jozsa L. Histopathological changes preceding spontaneous rupture of a tendon. A controlled study of 891 patients. J Bone Joint Surg Am 1991;73:1507-25.
24. Jarvinen TA, Jarvinen TL, Kannus P et al. Collagen fibres of the spontaneously ruptured human tendons display decreased thickness and crimp angle. J Orthop Res 2004;22:1303-9.
25. Yu JS, Popp JE, Kaeding CC et al. Correlation of MR imaging and pathologic findings in athletes undergoing surgery for chronic patellar tendinitis. AJR Am J Roentgenol 1995;165:115-8.
26. Fenwick S, Harrall R, Hackney R et al. Endochondral ossification in Achilles and patella tendinopathy. Rheumatology 2002;41:474-6.
27. Maffulli N, Reaper J, Ewen SE et al. Chondral metaplasia in calcific insertional tendinopathy of the Achilles tendon. Clin J Sport Med 2006;16:329-34.
28. Coleman BD, Khan KM, Kiss ZS et al. Open and arthroscopic patellar tenotomy for chronic patellar tendinopathy. A retrospective outcome study. Victorian Institute of Sport Tendon Study Group. Am J Sports Med 2000;28:183-90.
29. Khan KM, Bonar F, Desmond PM et al. Patellar tendinosis (jumper's knee):findings at histopathologic examination, US, and MR imaging. Victorian Institute of Sport Tendon Study Group. Radiology 1996;200:821-7.
30. Lagier R, Gerster JC. Disabling ossification of the patellar tendon. Ann Rheum Dis 1991;50:338-9.
31. Bosworth BM. Calcium deposits in the shoulder and subacromial bursitis:a survey of 12,122 shoulders. JAMA 1941;116:2477-82.
32. Aina R, Cardinal E, Bureau NJ et al. Calcific shoulder tendinitis:treatment with modified US-guided fine-needle technique. Radiology 2001;221:455-61.
33. Hashimoto T, Nobuhara K, Hamada T. Pathologic evidence of degeneration as a primary cause of rotator cuff tear. Clin Orthop Relat Res 2003;415:111-20.
34. Jim YF, Hsu HC, Chang CY et al. Coexistence of calcific tendinitis and rotator cuff tear:an arthrographic study. Skeletal Radiol 1993;22:183-5.
35. Rui YF, Lui PP, Rolf CG et al. Expression of chondroosteogenic BMPs in clinical samples of patellar tendinopathy. Knee Surg Sports Traumatol Arthrosc 2012;20:1409-17.
36. Lui PPY, Fu SC, Chan LS et al. Chondrocyte phenotype and ectopic ossification in collagenase-induced tendon degeneration. J Histochem Cytochem 2009;57:91-100.
37. Ducy P, Karsenty G. The family of bone morphogenetic proteins. Kidney Int 2000;57:2207-14.
38. Helm GA, Li JZ, Alden TD et al. A light and electron microscopic study of ectopic tendon and ligament formation induced by bone morphogenetic protein-13 adenoviral gene therapy. J Neurosurg 2001;95:298-307.
39. Koch H, Jadlowiec JA, Fu FH et al. The effect of growth/ differentiation factor-5 (GDF-5) on genotype and phenotype in human adult mesenchymal stem cells. Z Orthop Ihre Grenzqeb 2004;142:248-53.
40. Violini S, Ramelli P, Pisani LF et al. Horse bone marrow mesenchymal stem cells express embryo stem cell markers and show the ability for tenogenic differentiation by in vitro exposure to BMP-12. BMC Cell Biol 2009;10:29.
41. Wolfman NM, Hattersley G, Cox K et al. Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6 and 7, members of the TGF-b gene family. J Clin Invest 1997;100:321-30.
42. Forslund C, Aspenberg P. CDMP-2 induces bone or tendon-like tissue depending on mechanical stimulation. J Orthop Res 2002;20:1170-4.
43. Hotten GC, Matsumoto T, Kimura M et al. Recombinant human growth/differentiation factor 5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development of limbs. Growth Factors 1996;13:65-74.
44. Kakudo N, Wang YB, Miyake S et al. Analysis of osteochondro-induction using growth and differentiation factor-5 in rat muscle. Life Sci 2007;81:137-43.
45. Lou J, Tu Y, Ludwig FJ et al. Effect of bone morphogenetic protein-12 gene transfer on mesenchymal progenitor cells. Clin Orthop Relat Res 1999;369:333-9.
46. Kang Q, Song WX, Luo W et al. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev 2009;18:545-59.
47. Li JZ, Li H, Sasaki T et al. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Ther 2003;10:1735-43.
48. Bahamonde ME, Lyons KM. BMP3:to be or not to be a BMP. J Bone Joint Surg Am 2001;83-A Suppl 1(Pt 1): S56-62.
49. Kang Q, Sun MH, Cheng H et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 2004;11:1312-20.
50. Matsubara T, Kida K, Yamaguchi A et al. BMP2 regulates osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 2008;283:29119-25.
51. Amano K, Ichida F, Sugita A et al. Msx2 stimulates chondrocyte maturation by controlling Ihh expression. J Biol Chem 2008;283:29513-21.
52. Hoshino M, Egi T, Terai H et al. Repair of long intercalated rib defects in dogs using recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate. J Biomed Mater Res A 2009;90:514-21.
53. Ma CB, Kawamura S, Deng XH et al. Bone morphogenetic proteins-signaling plays a role in tendon-to-bone healing: a study of rhBMP-2 and noggin. Am J Sports Med 2007;35:597-604.
54. Jiang Y, Chen LK, Zhu DC et al. The inductive effect of bone morphogenetic protein-4 on chondral-lineage differentiation and in situ cartilage repair. Tissue Eng Part A 2010;16:1621-32.
55. Schulz TJ, Tseng YH. Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism. Cytokine Growth Factor Rev 2009;20:523-31.
56. Rui YF, Lui PPY, Wong YM et al. BMP-2 stimulated non-tenogenic differentiation and promoted proteoglycan deposition of tendon-derived stem cells (TDSCs). J Orthop Res 2013;31:746-53.
57. Yee Lui PP, Wong YM, Rui YF et al. Expression of chondro-osteogenic BMPs in ossified failed tendon healing model of tendinopathy. J Orthop Res 2011;29:816-21.
58. Lui PPY, Chan LS, Cheuk YC et al. Expression of bone morphogenetic protein-2 in the chondrogenic and ossifying sites of calcific tendinopathy and traumatic tendon injury rat models. J Orthop Surg Res 2009;4:27.
59. Neuwirth J, Fuhrmann RAE, Veit A et al. Expression of bioactive bone morphogenetic proteins in the subacromial bursa of patients with chronic degeneration of the rotator cuff. Arthritis Res Ther 2006;8:R92.
60. Lui PP, Chan KM. Tendon-derived stem cells (TDSCs): from basic science to potential roles in tendon pathology and tissue engineering applications. Stem Cell Rev 2011;7:883-97.
61. Kim SY, Choi HY, Myung KB et al. The expression of molecular mediators in the idiopathic cutaneous calcification and ossification. J Cutan Pathol 2008;35:826-31.
62. Li H, Jiang LS, Dai LY. Hormones and growth factors in the pathogenesis of spinal ligament ossification. Eur Spine J 2007;16:1075-84.
63. Sato K, Miura T, Iwata H. Cartilaginous transdifferentiation of rat tenosynovial cells under the influence of bone morphogenetic protein in tissue culture. Clin Orthop Relat Res 1988;236:233-9.
64. Oliva F, Barisani D, Grasso A et al. Gene expression analysis in calcific tendinopathy of the rotator cuff. Eur Cell Mater 2011;21:548-57.
65. Luu HH, Song WX, Luo X et al. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res 2007;25:665-77.
66. Sharma P, Maffulli N. Basic biology of tendon injury and healing. Surgeon 2005;3:309-16.
67. Bi Y, Ehirchiou D, Kilts TM et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 2007;13:1219-27.
68. Rui YF, Lui PP, Li G et al. Isolation and characterization of multipotent rat tendon-derived stem cells. Tissue Eng Part A 2010;16:1549-58.
69. Zhang J, Wang JH. Characterization of differential properties of rabbit tendon stem cells and tenocytes. BMC Musculoskelet Disord 2010;11:10.
70. Rui YF, Lui PP, Wong YM et al. Altered fate of tendonderived stem cells (TDSCs) isolated from a failed tendon healing animal model of tendinopathy. Stem Cells Dev 2013;22:1076-85.
71. Rui YF, Lui PP, Chan LS et al. Does erroneous differentiation of tendon-derived stem cells contribute to the pathogenesis of calcifying tendinopathy? Chin Med J (Engl) 2011;124:606-10.
72. Hashimoto Y, Yoshida G, Toyoda H et al. Generation of tendon-to-bone interface 'enthesis' with use of recombinant BMP-2 in a rabbit model. J Orthop Res 2007;25:1415-24.
73. Wong YM, Lui PPY, Rui YF et al. Tendon-derived stem cells (TDSCs) isolated from the collagenase-induced failed healing animal model of tendinopathy exhibited higher sensitivity to the BMP/Smad signaling pathway. Proceedings of the 58th Annual Meeting of the Orthopaedic Research Society, 4-7 February 2012, Moscone West Convention Center, San Francisco, CA, USA.
74. Billings PC, Fiori JL, Bentwood JL et al. Dysregulated BMP signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressive (FOP). J Bone Miner Res 2008;23:305-13.
75. Boyd NL, Dhara SK, Rekaya R et al. BMP4 promotes formation of primitive vascular networks in human embryonic stem cell-derived embryoid bodies. Exp Biol Med 2007;232:833-43.
76. Bressan M, Davis P, Timmer J et al. Notochord-derived BMP antagonists inhibit endothelial cell generation and network formation. Dev Biol 2009;326:101-11.
77. Raida M, Heymann AC, Gunther C et al. Role of bone morphogenetic 2 in the cross-talk between endothelial progenitor cells and mesenchymal stem cells. Int J Mol Med 2006;18:735-9.
78. Reese DE, Hall CE, Mikawa T. Negative regulation of midline vascular development by the notochord. Dev Cell 2004;6:699-708.
79. Kajikawa Y, Morihara T, Watanabe N et al. GFP chimeric models exhibited a biphasic pattern of mesenchymal cell invasion in tendon healing. J Cell Physiol 2007;210:684-91.
80. Rui YF, Lui PP, Ni M et al. Mechanical loading increased BMP-2 expression which promoted osteogenic differentiation of tendon-derived stem cells. J Orthop Res 2011;29:390-6.
81. Schweitzer R, Chyung JH, Murtaugh LC et al. Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development 2001;128:3855-66.
82. Zhang J, Wang JHC. BMP-2 mediates PGE2-induced reduction of proliferation and osteogenic differentiation of human tendon stem cells. J Orthop Res 2012;30:47-52.
83. Johnson DP, Wakeley CJ, Watt I. Magnetic resonance imaging of patellar tendonitis. Bone Joint Surg Br 1996;78:452-7.
84. Ahrens M, Ankenbauer T, Schroder D et al. Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol 1993;12:871-80.
85. Bachner D, Ahrens M, Schroder D et al. BMP-2 downstream targets in mesenchymal development identified by subtractive cloning from recombinant mesenchymal progenitors (C3H10T1/2). Dev Dyn 1998;213:398-411.
86. Asahina I, Sampath TK, Hauschka PV. Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res 1996;222:38-47.
87. Chen TL, Shen WJ, Kraemer FB. Human BMP-2/OP-1 induces the growth and differentiation of adipocytes and osteoblasts in bone marrow stromal cell cultures. J Cell Biochem 2001;82:187-99.
88. Knippenberg M, Helder MN, Zandieh Doulabi B et al. Osteogenesis versus chondrogenesis by BMP-2 and BMP-7 in adipose stem cells. Biochem Biophys Res Commun 2006;342:902-8.
89. Wang EA, Israel DI, Kelly S et al. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 1993;9:57-71.
90. de Mos M, Koevoet W, ven Schie HTM et al. In vitro model to study chondrogenic differentiation in tendinopathy. Am J Sports Med 2009;37:1214-22.
91. Zeckey C, Hildebrand F, Frink M et al. Heterotopic ossifications following implant surgery-epidemiology, therapeutical approaches and current concepts. Semin Immunopathol 2011;33:273-86.
92. Macfarlane RJ, Ng BH, Gamie Z et al. Pharmacological treatment of heterotopic ossification following hip and acetabular surgery. Expert Opin Pharmacother 2008;9:767-86.
93. Zhang J, Keenan C, Wang JH. The effects of dexamethasone on human patellar tendon stem cells: implications for dexamethasone treatment of tendon injury. J Orthop Res 2013;31:105-10.
94. Murata H, Tanaka H, Taguchi T et al. Dexamethasone induces human spinal ligament derived cells toward osteogenic differentiation. J Cell Biochem 2004;92:715-22.
95. Riley GP. Gene expression and matrix turnover in overused and damaged tendons. Scand J Med Sci Sports 2005;15:241-51.
96. Riley G. Chronic tendon pathology:molecular basis and therapeutic implications. Expert Rev Mol Med 2005;7:1-25.
97. Riley GP, Harrall RL, Contant CR et al. Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis 1994;53:367-76.
98. Smith MM, Sakurai G, Smith SM et al. Modulation of aggrecan and ADAMTS expression in ovine tendinopathy induced by altered strain. Arthritis Rheum 2008;58:1055-66.
99. Ameye L, Aria D, Jepsen K et al. Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J 2002;16:673-80.
100. Danielson KG, Baribault H, Holmes DF et al. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997;136:729-43.
101. Svensson L, Aszodi A, Reinholt FP et al. Fibromodulinnull mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J Biol Chem 1999;274:9636-47.
102. Yin Z, Chen X, Chen JL et al. The regulation of tendon stem cell differentiation by the alignment of nanofibers. Biomaterials 2010;31:2163-75.
103. Barry F, Boynton RF, Liu B et al. Chondrogenic differentiation of mesenchymal stem cells from bone marrow:differentiation-dependent gene expression of matrix components. Exp Cell Res 2001;268:189-200.
104. Dai J, Kitagawa Y, Zhang Y et al. Vascular endothel growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein. Cancer Res 2004;64:994-9.
105. Deckers MM, van Bezooijen RL, van der Horst G et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002;143:1545-53.
106. Levi B, Nelson ER, Hyun JS et al. Enhancement of human adipose-derived stromal cell angiogenesis through knockdown of a BMP-2 inhibitor. Plast Reconstr Surg 2012;129:53-66.
107. Speer MY, Yang HY, Brabb T et al. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res 2009;104:733-41.
108. Tanno M, Furukawa KI, Ueyama K et al. Uniaxial cyclic stretch induces osteogenic differentiation and synthesis of bone morphogenetic proteins of spinal ligament cells derived from patients with ossification of the posterior longitudinal ligaments. Bone 2003;33:475-84.
109. Zhang J, Wang JH. Mechanobiological response of tendon stem cells:implications of tendon homeostasis and pathogenesis of tendinopathy. J Orthop Res 2010;28:639-43.
110. Shi Y, Fu Y, Tong W et al. Uniaxial mechanical tension promoted osteogenic differentiation of rat tendon-derived stem cells (rTDSCs) via the Wnt5a-RhoA pathway. J Cell Biochem 2012;113:3133-42.
111. Csiszar A, Labinskyy N, Smith KE et al. Downregulation of bone morphogenetic protein 4 expression in coronary arterial endothelial cells:role of shear stress and the cAMP/protein kinase A pathway. Arterioscler Thromb Vasc Biol 2007;27:776-82.
112. Siddhivarn C, Banes A, Champagne C et al. Mechanical loading and -12prostaglandin J2 induce bone morphogenetic protein-2, peroxisome proliferatoractivated receptor g-1 and bone nodule formation in an osteoblastic cell line. J Periodont Res 2007;42:383-92.
113. Feng JQ, Harris MA, Ghosh-Choundhury N et al. Structure and sequence of mouse bone morphogenetic protein-2 gene (BMP-2):comparison of the structures and promoter regions of BMP-2 and BMP-4 genes. Biochim Biophys Acta 1994;1218:221-4.
114. Feng JQ, Chen D, Cooney AJ et al. The mouse bone morphogenetic protein-4 gene:analysis of promoter utilization in fetal rat calvarial osteoblast and regulation by COUP-TFI orphan receptor. J Biol Chem 1995;270:28364-73.
115. Arnoczky SP, Lavagnino M, Egerbacher M. The response of tendon cells to changing loads: implications in the etiopathogenesis of tendinopathy. In:Woo SLY, Renstrom PAFH, Arnoczky SP, eds. Tendinopathy in athletes. Oxford, UK:Blackwell, 2007,46-59.
116. Rath B, Nam J, Knobloch TJ et al. Compressive forces induce osteogenic gene expression in calvarial osteoblasts. J Biomech 2008;41:1095-103.
117. Mitsui N, Suzuki N, Maeno M et al. Optimal compressive force induces bone formation via increasing bone morphogenetic proteins production and decreasing their antagonists production by Saos-2 cells. Life Sci 2006;78:2697-706.
118. Seib FP, Franke M, Jing D et al. Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells. Eur J Cell Biol 2009;88:257-71.
119. Chen Y, Whetstone HC, Youn A et al. b-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J Biol Chem 2007;282:526-33.
120. Rawadi G, Vayssiere B, Dunn F et al. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 2003;18:1842-53.
121. Shea CM, Edgar CM, Einhorn TA et al. BMP treatment of C3H10T1/2 mesenchymal stem cells induces both chondrogenesis and osteogenesis. J Cell Biochem 2003;90:1112-27.
122. Winkler DG, Sutherland MS, Ojala E et al. Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins. J Biol Chem 2005;280:2498-502.
123. Lui PPY, Lee YW, Wong YM et al. Expression of Wnt pathway mediators in metaplastic tissue in animal model and clinical samples of tendinopathy. Rheumatology 2013;52:1609-18.
124. Al-Aly Z, Shao JS, Lai CF et al. Aortic Msx2-Wnt calcification cascade is regulated by TNF-alphadependent signals in diabetic Ldlr-/- mice. Arterioscler Thromb Vasc Biol 2007;27:2589-96.
125. Shao JS, Aly ZA, Lai CF et al. Vascular BMP Msx2 Wnt signaling and oxidative stress in arterial calcification. Ann N Y Acad Sci 2007;1117:40-50.
126. Shao JS, Pingsterhaus JM, Cheng SL et al. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 2005;115:1210-20.
127. Zhang J, Wang JH. Production of PGE(2) increases in tendons subjected to repetitive mechanical loading and induces differentiation of tendon stem cells into non-tenocytes. J Orthop Res 2010;28:198-203.
128. Lui PP, Chan LS, Fu SC et al. Expression of sensory neuropeptides in tendon is associated with failed healing and activity-related tendon pain in collagenaseinduced tendon injury. Am J Sports Med 2010;38:757-64.
129. Ai X, Cappuzzello J, Hall AK. Activin and bone morphogenetic proteins induce calcitonin gene-related peptide in embryonic sensory neurons in vitro. Mol Cell Neurosci 1999;14:506-18.
130. Bucelli RC, Gonsiorek EA, Kim WY et al. Statins decrease expression of the proinflammatory neuropeptides calcitonin gene-related peptide and substance P in sensory neurons. J Pharmacol Exp Ther 2008;324:1172-80.
131. Kan L, Lounev VY, Pignolo RJ et al. Substance P signaling mediates BMP dependent heterotopic ossification. J Cell Biochem 2011;112:2759-72.
132. Salisbury E, Sonnet C, Heggeness M et al. Heterotopic ossification has some nerve. Crit Rev Eukaryot Gene Expr 2010;20:313-24.
133. Nakashima A, Tamura M. Regulation of matrix metalloproteinase-13 and tissue inhibitor of matrix metalloproteinase-1 gene expression by WNT3A and bone morphogenetic protein-2 in osteoblastic differentiation. Front Biosci 2006;11:1667-78.
134. Wang YK, Sun WF, Liu XG et al. Comparative study of serum levels of BMP-2 and heterotopic ossification in traumatic brain injury and fractures patients. Zhongguo Gu Shang 2011;24:399-403.
135. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004;22:233-41.
136. Glaser DL, Economides AN, Wang L et al. In vivo somatic cell gene transfer of an engineered noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg Am 2003;85A:2332-42.
137. Hannallah D, Peng H, Young B et al. Retroviral delivery of noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model. J Bone Joint Surg Am 2004;86A:80-91.
138. Zhang J, Pan T, Liu Y et al. Mouse treadmill running enhances tendons by expanding the pool of tendon stem cells (TDCs) and TSC-related cellular production of collagen. J Orthop Res 2010;28:1178-83.
139. Larsson ME, Kall I, Nilsson-Helander K. Treatment of patellar tendinopathy-a systematic review of randomized controlled trials. Knee Surg Sports Traumatol Arthrosc 2012;20:1632-46.
140. Lui PPY, Ng SW. Cell therapy for the treatment of tendinopathy-a systematic review on the pre-clinical and clinical evidence. Semin Arthritis Rheum 2013, doi:10.1016/ j.semarthrit.2012.10.004.
141. Lui PPY, Wong OT. Tendon stem cells:experimental and clinical perspectives in tendon and tendon-bone junction repair. MLTJ 2012;3:163-8.
142. Gaida JE, Alfredson L, Kiss ZS et al. Dyslipidemia in Achilles tendinopathy is characteristic of insulin resistance. Med Sci Sports Exerc 2009;41:1194-7.
143. Lui PPY, Maffull N, Rolf C et al. What are the validated animal models of tendinopathy? Scand J Med Sci Sports 2011;21:3-17.